SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+9.33%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$899M
AUM Growth
+$899M
(+31%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
11.33%
Top 10 Holdings %
Top 10 Hldgs %
65.2%
Holding
49
New
13
Increased
20
Reduced
8
Closed
8
Top Buys
| 1 |
Bausch Health
BHC
|
$132M |
| 2 |
AGN
Allergan plc
AGN
|
$38.9M |
| 3 |
Centene
CNC
|
$17.1M |
| 4 |
Universal Health Services
UHS
|
$16.2M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$10.2M |
Top Sells
| 1 |
Viatris
VTRS
|
$50.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$35.3M |
| 3 |
Amgen
AMGN
|
$28.7M |
| 4 |
Cigna
CI
|
$23.4M |
| 5 |
STJ
St Jude Medical
STJ
|
$22.4M |
Sector Composition
| 1 | Healthcare | 87.72% |
| 2 | Financials | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNTA
26
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $8.04M | 0.89% |
+542,091
| New | +$8.04M |
|
27
DaVita
DVA
$9.72B
| $6.61M | 0.73% |
+94,800
| New | +$6.61M |
|
28
Select Medical
SEM
$1.6B
| $5.86M | 0.65% |
+492,000
| New | +$5.86M |
|
|
FPRX
29
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $5.62M | 0.63% |
+135,535
| New | +$5.62M |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $5.57M | 0.62% |
377,600
+306,300
| +430% | +$4.51M |
|
31
Enanta Pharmaceuticals
ENTA
$189M
| $5.41M | 0.6% |
+163,986
| New | +$5.41M |
|
|
AVDL
32
Avadel Pharmaceuticals
AVDL
$1.42B
| $5.39M | 0.6% |
+441,500
| New | +$5.39M |
|
33
Esperion Therapeutics
ESPR
$490M
| $4.98M | 0.55% |
+223,700
| New | +$4.98M |
|
34
Rigel Pharmaceuticals
RIGL
$710M
| $4.59M | 0.51% |
1,513,500
+137,913
| +10% | +$418K |
|
|
AGRX
35
DELISTED
Agile Therapeutics, Inc
AGRX
| $3.77M | 0.42% |
+386,569
| New | +$3.77M |
|
|
VXRT
36
DELISTED
Vaxart
VXRT
| $3.71M | 0.41% |
1,910,476
+174,076
| +10% | +$338K |
|
|
ARNA
37
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.69M | 0.41% |
1,944,091
+177,100
| +10% | +$336K |
|
38
Rocket Pharmaceuticals
RCKT
$358M
| $3.51M | 0.39% |
+309,600
| New | +$3.51M |
|
|
NDRM
39
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $3.44M | 0.38% |
201,700
+145,700
| +260% | +$2.48M |
|
|
SIEN
40
DELISTED
Sientra, Inc.
SIEN
| $3.44M | 0.38% |
580,851
+336,565
| +138% | +$1.99M |
|
|
ADYX
41
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $2.17M | 0.24% |
1,014,103
+92,457
| +10% | +$198K |
|
|
XNPT
42
DELISTED
XENOPORT, INC.
XNPT
| – | – |
-2,150,090
| Closed | -$7.46M |
|
|
ACHN
43
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – |
-619,000
| Closed | -$4.28M |
|
44
Xoma
XOMA
$421M
| – | – |
-2,327,100
| Closed | -$1.75M |
|
45
Orthofix Medical
OFIX
$583M
| – | – |
-134,984
| Closed | -$4.56M |
|
46
Standard BioTools
LAB
$493M
| – | – |
-310,587
| Closed | -$2.52M |
|
|
47
Cigna
CI
$80.2B
| – | – |
-173,600
| Closed | -$23.4M |
|
|
48
Amgen
AMGN
$153B
| – | – |
-207,400
| Closed | -$28.7M |
|
49
MiMedx Group
MDXG
$1.05B
| – | – |
-416,361
| Closed | -$4.02M |
|